ICH looks to revamp its guidelines on cell and gene therapies
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsGlobalHealth Authority meeting and communication strategyICHManufacturingPharmaceuticalsRegulatory Intelligence/Policy